IDEXX Laboratories (XTER:IX1) Construction In Progress: €0 Mil (As of Mar. 2026)


XTER:IX1 IDEXX Laboratories Inc XTER:IX1
96 GF Score
Price €488.90
GF Value €559.26
View Full Analysis

What is IDEXX Laboratories Construction In Progress?

IDEXX Laboratories XTER:IX1 96 Construction In Progress is €0 Mil as of Mar. 2026. GuruFocus rates XTER:IX1 with a GF Score™ of 96/100 and a GF Value™ of €559.26.

IDEXX Laboratories's quarterly construction in progress increased from Sep. 2025 (€0 Mil) to Dec. 2025 (€59 Mil) but then declined from Dec. 2025 (€59 Mil) to Mar. 2026 (€0 Mil).

IDEXX Laboratories's annual construction in progress declined from Dec. 2023 (€72 Mil) to Dec. 2024 (€64 Mil) and declined from Dec. 2024 (€64 Mil) to Dec. 2025 (€59 Mil).

IDEXX Laboratories Construction In Progress Historical Data

* Premium members only.

The historical data trend for IDEXX Laboratories's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories Construction In Progress Chart

IDEXX Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.17 91.86 72.50 64.12 58.91

IDEXX Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 58.91 0.00
XTER:IX1
96GF Score
IDEXX Laboratories Inc XTER:IX1
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEXX Laboratories Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of €0 Mil mean?
IDEXX Laboratories (XTER:IX1) has a Construction In Progress of €0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on IDEXX Laboratories and its competitors.
Is IDEXX Laboratories' Construction In Progress too high?
IDEXX Laboratories' current Construction In Progress is €0 Mil. Overall, IDEXX Laboratories has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does IDEXX Laboratories' Construction In Progress compare to A and WAT?
IDEXX Laboratories' Construction In Progress of €0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Diagnostics & Research company?
A good Construction In Progress depends on the Medical Diagnostics & Research industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on IDEXX Laboratories and its competitors. IDEXX Laboratories's current Construction In Progress is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEXX Laboratories stock overvalued right now?
IDEXX Laboratories (XTER:IX1) has a current Construction In Progress of €0 Mil. The stock's GF Value™ is €559.26, compared to a current price of €488.90 — trading 12.6% below its estimated fair value. The current Construction In Progress is €0 Mil. IDEXX Laboratories' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For IDEXX Laboratories (XTER:IX1), the current Construction In Progress is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEXX Laboratories (XTER:IX1) Overvalued in 2026?

Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued. The current stock price of €488.90 is trading 12.6% below its estimated GF Value™ of €559.26.

Key valuation signals for XTER:IX1:

  • Construction In Progress: €0 Mil
  • GF Value™: €559.26 vs. price of €488.90 (12.6% below fair value)
  • GF Score™: 96/100

No single metric tells the full story. See the XTER:IX1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDEXX Laboratories Business Description

Address One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
96GF Score

Get the complete analysis for XTER:IX1

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€488.90
Price
€559.26
GF Value